| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/16/2008 | CN100381171C Composite hepatitis B virus surface antigen granule containing S1, S2 and S proantigen determinants |
| 04/16/2008 | CN100381170C Foot and mouth disease bivalent polypeptide vaccine and its preparation method and use |
| 04/16/2008 | CN100381043C Temperature-sensitive rice male sterility line breeding method with Honglian cytoplasm |
| 04/15/2008 | US7358426 Inbred corn line G7905 |
| 04/15/2008 | US7358422 Soybean cultivar 4136015 |
| 04/15/2008 | US7358421 Soybean cultivar 3133014 |
| 04/15/2008 | US7358420 Soybean cultivar S040131 |
| 04/15/2008 | US7358419 Enhanced silk exsertion under stress |
| 04/15/2008 | US7358418 Eukaryotic initiation factor 5A (eIF-5A) for use as tool in identifying modulators which prevent browning in plants; controlling aging in plants; enzyme inhibitors; storage stability; enhamced shelf life |
| 04/15/2008 | US7358417 A DNA molecule exhibiting resistance to an enhanced accumulation of lead and encoding a fungal multidrug resistance-associated protein (MRP)-like ATP-binding cassette transporter protein (MRP-like ABC transporter protein) |
| 04/15/2008 | US7358416 Transgenic mouse expressing human FcRn protein |
| 04/15/2008 | US7358415 comprises administering the hepatocytes or plasma cells or T cells to an animal after stimulation in vitro |
| 04/15/2008 | US7358355 Antibodies against human parathyroid hormone related protein |
| 04/15/2008 | US7358354 Administering genetically engineered vectors to modulate lymphocytes; transfecting macrophages; used for prophylaxis or treatments for cancers or immune-related disorders |
| 04/15/2008 | US7358353 Expose cells to gene and nucleotide sequence that encodes T or B cell epitope; generates antibodies that bind specifically; immunogenic |
| 04/15/2008 | US7358352 Tumor necrosis factor; isolating protein from cell culture; use in drug discovery screens compounds that block synthesis |
| 04/15/2008 | US7358351 Endothelial cell expression patterns |
| 04/15/2008 | US7358350 Oncogene, recombinant protein derived therefrom, and uses thereof |
| 04/15/2008 | US7358349 Nucleic acids having expression differentials between hepatoblastoma and normal liver |
| 04/15/2008 | US7358348 β-catenin nuclear localized protein |
| 04/15/2008 | US7358341 Secreted protein for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 04/15/2008 | US7358333 Polypeptides of the IFNα-5 gene |
| 04/15/2008 | US7358331 Truncated fragments of alpha-synuclein in Lewy body disease |
| 04/15/2008 | US7358329 Antagonists to chaperonin 10 |
| 04/15/2008 | US7358234 Induction of a protective immune response through microprojectiles coated with a DNA sequence encoding an immunogenic protein |
| 04/15/2008 | US7358228 Methods of treating pain using neurotrophic factors |
| 04/15/2008 | US7358222 Administering a therapeutically effective amount of an epidermal growth factor receptor (EGF-R) antagonist for therapy of hypersecretion of mucus in lungs |
| 04/15/2008 | US7358090 Establishment of cellular manipulations which enhance oligo-mediated gene targeting |
| 04/15/2008 | US7358086 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| 04/15/2008 | US7358084 Enhanced secretion of a polypeptide by a microorganism |
| 04/15/2008 | US7358083 Lactococcus lactis cells with nonsense mutation in pyr gene; transforming with vector that lacks antibiotic resistance gene; bacteriophage lysin; use in preparation of feed products or dairy flavor |
| 04/15/2008 | US7358074 Human phosphatase RET31, and variants thereof |
| 04/15/2008 | US7358071 Production of 3-hydroxycarboxylic acid using nitrilase mutants |
| 04/15/2008 | US7358070 Ink jet application of 3-hydroxyacyl coenzyme A containing solution and enzyme catalyzed polymerization; biological testing probes and arrays |
| 04/15/2008 | US7358069 for use in the expression of double-stranded RNA in vitro and in vivo; gene expression inhibition; genetic engineering |
| 04/15/2008 | US7358068 For use as therapeutic agents in viral infections by human and animal viruses and in cancers caused by oncogene viruses; non-sequence complementary mode of action; drug screening |
| 04/15/2008 | US7358067 Genetic engineering; forming protein, peptide, polypeptide |
| 04/15/2008 | US7358066 Variants and exons of the GlyT1 transporter |
| 04/15/2008 | US7358061 Methods of diagnosing thyroid carcinoma |
| 04/15/2008 | US7358058 Method and agents for the diagnosis and therapy of chronic inflammatory intestinal disease |
| 04/15/2008 | US7358057 QM-7 and QT-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells |
| 04/15/2008 | US7358055 Diagnostic markers of acute coronary syndrome and methods of use thereof |
| 04/15/2008 | US7358054 Crystal structure of the complex between one such antibody and the alpha 1-I domain of VLA-1, and to the use of this structural information for computational drug design |
| 04/15/2008 | US7358053 Methods for detecting and reversing resistance to macrocyclic lactone compounds |
| 04/15/2008 | US7358043 Generation of gene expression map; obtain sample cells, generate expression pattern for preferential genes, monitor activities associated with pattern and compare to control, evaluate for genetic defect |
| 04/15/2008 | US7357928 Proteins for treatment of cancer by administering antinucleolin |
| 04/15/2008 | US7356965 Multi-embryo manufactured seed |
| 04/15/2008 | CA2438327C Improved method for bisulfite treatment |
| 04/15/2008 | CA2250433C Human dnase ii |
| 04/15/2008 | CA2243546C Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques |
| 04/15/2008 | CA2181042C Bacterial receptor structures |
| 04/15/2008 | CA2171110C Detection of amplified or deleted chromosomal regions |
| 04/15/2008 | CA2169764C Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies |
| 04/13/2008 | CA2561408A1 Method for improving stress tolerance during fermentation |
| 04/12/2008 | CA2563214A1 Shigella ipad protein and its use as a potential vaccine against shigella infection |
| 04/10/2008 | WO2008043102A2 Vasoactive intestinal polypeptide compositions |
| 04/10/2008 | WO2008043076A2 Use of low ph to modify the texture of structured plant protein products |
| 04/10/2008 | WO2008042473A1 Devices, vectors and methods for inducible cardioprotection |
| 04/10/2008 | WO2008042469A2 Knockout mice for different genes and their use for gene characterizatio |
| 04/10/2008 | WO2008042185A2 Resistance to gray leaf spot in maize |
| 04/10/2008 | WO2008042067A2 Compositions and methods for nucleotide sequencing |
| 04/10/2008 | WO2008042026A2 Uses of the pseudomonas syringae effector protein hopu1 related to its ability to adp-ribosylate eukaryotic rna binding proteins |
| 04/10/2008 | WO2008042001A1 High throughput screening methods for anti-metastatic compounds |
| 04/10/2008 | WO2008041933A2 Rna interference against wrap53 to treat hyperproliferative diseases |
| 04/10/2008 | WO2008041863A1 Novel genes and polypeptides associated with insecticidal activity |
| 04/10/2008 | WO2008041825A1 Mutant dna polymerases and their genes |
| 04/10/2008 | WO2008041767A1 Gene/protein marker for prediction or diagnosis of pharmacological efficacy of aurora a inhibitor |
| 04/10/2008 | WO2008041693A1 Tool for screening of plant having useful trait and use thereof |
| 04/10/2008 | WO2008041665A1 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c |
| 04/10/2008 | WO2008041505A1 Novel bacillus bacterium strain capable of degrading/volume-reducing plant residue |
| 04/10/2008 | WO2008041385A1 Novel alkane polyol dehydrogenase |
| 04/10/2008 | WO2008041354A1 Detection of bacterium by utilizing dnaj gene and use thereof |
| 04/10/2008 | WO2008041272A1 Novel highly active modified type s-hydroxynitrile lyase |
| 04/10/2008 | WO2008041047A1 An artificially synthesized peptide |
| 04/10/2008 | WO2008041014A2 Interferon- alpha constructs for use in the treatment of diseases characterised by abnormal cell proliferation such as cancer |
| 04/10/2008 | WO2008040834A1 Method for assessing the efficiency of abiotic stress tolerance genes in transgenic plants |
| 04/10/2008 | WO2008040802A1 Use of mva as adjuvant in the stimulation of antigen-presenting cells |
| 04/10/2008 | WO2008040793A1 Method for obtaining variants of lactic bacteria useful in the production of k2 vitamin and applications for the preparation of food products |
| 04/10/2008 | WO2008040792A2 Compositions comprising a sirna and lipidic 4,5-disubstituted 2-deoxystreptamine ring aminoglycoside derivatives and uses thereof |
| 04/10/2008 | WO2008040787A2 Processes for producing polyunsaturated fatty acids in transgenic organisms |
| 04/10/2008 | WO2008040758A1 Peptides with high affinity for the prolactin receptor |
| 04/10/2008 | WO2008040740A1 Lipolytic enzyme variants |
| 04/10/2008 | WO2008040738A1 Lipolytic enzyme variants |
| 04/10/2008 | WO2008040599A1 Process for the production of recombinant proteins using carnivorous plants. |
| 04/10/2008 | WO2008040387A1 Process for chromosomal integration and dna sequence replacement in clostridia |
| 04/10/2008 | WO2008040358A1 A method for providing proteins and fermentation products from a plant material |
| 04/10/2008 | WO2008040190A1 Small peptides for anti-angiogenesis and use thereof |
| 04/10/2008 | WO2008040155A1 Oral recombinant helicobacter pylori vaccine and preparing method thereof |
| 04/10/2008 | WO2008040126A1 Stabilizing compositions and methods for extraction of ribonucleic acid |
| 04/10/2008 | WO2008040111A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/10/2008 | WO2008040061A1 Nucleic acid promoter sequences that control gene expression in plants |
| 04/10/2008 | WO2008040060A1 Vlp based vaccine delivery system |
| 04/10/2008 | WO2008024518A3 Hcv fusion polypeptides |
| 04/10/2008 | WO2008017483A3 Spore surface displays of bioactive molecules |
| 04/10/2008 | WO2008016473A3 Dinucleotide mrna cap analogs |
| 04/10/2008 | WO2008010925A3 Protease variants active over a broad temperature range |
| 04/10/2008 | WO2008009895A3 Matriptase-2 |
| 04/10/2008 | WO2008007073A3 Method for introducing sirna into cells by photochemical internalisation |
| 04/10/2008 | WO2007137129A3 RNAI-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR α-RELATED CONDITIONS |
| 04/10/2008 | WO2007132271A3 Method for the production of a type i interferon in a transgenic avian |